Every day, we see the strength.
Every week, we see Hope.
Every month, we need to make lupus visible.
Awareness is a continuous journey of compassion and support.
Thank you Washington School
Every day, we see the strength.
Every week, we see Hope.
Every month, we need to make lupus visible.
Awareness is a continuous journey of compassion and support.
Thank you Washington School
Kidney or Liquid Biopsy for Assessing Lupus Nephritis Activity
Andrea Fava
John Hopkins University School of Medicine, Division of Rheumatology, Baltimore, United States of America
@ladaorg.bsky.social
@lupuschat.bsky.social
#Lupus2025
#Lupuschat
#Lupus
Kidney or Liquid Biopsy for Assessing Lupus Nephritis Activity
Andrea Fava
John Hopkins University School of Medicine, Division of Rheumatology, Baltimore, United States of America
@ladaorg.bsky.social
@lupuschat.bsky.social
#Lupus2025
#Lupuschat
#Lupus
Dr. Victoria Werth is a Professor of Dermatology and Medicine at the Perelman School of Medicine at the University of Pennsylvania
@ladaorg.bsky.social
@lupuschat.bsky.social
#Lupus2025
#Lupuschat
#Lupus
Dr. Victoria Werth is a Professor of Dermatology and Medicine at the Perelman School of Medicine at the University of Pennsylvania
@ladaorg.bsky.social
@lupuschat.bsky.social
#Lupus2025
#Lupuschat
#Lupus
Meet-the-Professor Session: Refractory Skin Manifestation
Dr. Cheryl Rosen is a dermatologist at Toronto Western Hospital.
@ladaorg.bsky.social
@lupuschat.bsky.social
#LUPUS2025
#Lupuschat
#Lupus
Meet-the-Professor Session: Refractory Skin Manifestation
Dr. Cheryl Rosen is a dermatologist at Toronto Western Hospital.
@ladaorg.bsky.social
@lupuschat.bsky.social
#LUPUS2025
#Lupuschat
#Lupus
Clinical Scientific Session: Update on Lupus Nephritis, Novel Approaches in LN
"It is important to treat the kidney Holistically"
@ladaorg.bsky.social
@lupuschat.bsky.social
#Lupus2025
#Lupuschat
#Lupus
Clinical Scientific Session: Update on Lupus Nephritis, Novel Approaches in LN
"It is important to treat the kidney Holistically"
@ladaorg.bsky.social
@lupuschat.bsky.social
#Lupus2025
#Lupuschat
#Lupus
Helen Masson:
O026 - MULTI-OMIC INTEGRATION REVEALS THREE MOLECULAR SUBTYPES WITH DISTINCT IMMUNOLOGICAL PHENOTYPES IN A COHORT OF 722 SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS (ID 740)
@ladaorg.bsky.social
@lupuschat.bsky.social
#LUPUS2025
#LupusChat
#Lupus
Helen Masson:
O026 - MULTI-OMIC INTEGRATION REVEALS THREE MOLECULAR SUBTYPES WITH DISTINCT IMMUNOLOGICAL PHENOTYPES IN A COHORT OF 722 SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS (ID 740)
@ladaorg.bsky.social
@lupuschat.bsky.social
#LUPUS2025
#LupusChat
#Lupus
Richard A Furie:
O025 - RESULTS FROM THE REGENCY TRIAL ASSESSING EFFICACY AND SAFETY OF OBINUTUZUMAB IN ACTIVE LUPUS NEPHRITIS (ID 750)
@ladaorg.bsky.social
@lupuschat.bsky.social
#LUPUS2025
#Lupuschat
#Lupus
Richard A Furie:
O025 - RESULTS FROM THE REGENCY TRIAL ASSESSING EFFICACY AND SAFETY OF OBINUTUZUMAB IN ACTIVE LUPUS NEPHRITIS (ID 750)
@ladaorg.bsky.social
@lupuschat.bsky.social
#LUPUS2025
#Lupuschat
#Lupus
Abstract Concurrent Session 04: Advancing Lupus Therapies and Insights
0024 - ENDOTHELIAL BRD4 PARTICIPATES IN THE DEVELOPMENT OF LUPUS NEPHRITIS (ID 733)
Authors: Wang X., Zhang W., Ni X.
@ladaorg.bsky.social
@lupuschat.bsky.social
#LUPUS2025
#Lupuschat
#Lupus
Abstract Concurrent Session 04: Advancing Lupus Therapies and Insights
0024 - ENDOTHELIAL BRD4 PARTICIPATES IN THE DEVELOPMENT OF LUPUS NEPHRITIS (ID 733)
Authors: Wang X., Zhang W., Ni X.
@ladaorg.bsky.social
@lupuschat.bsky.social
#LUPUS2025
#Lupuschat
#Lupus
Breaking Barriers: Advancing Disease Modification and Early Intervention in SLE & LN with Patient-Centered Strategies
@ladaorg.bsky.social
@lupuschat.bsky.social
#LUPUS2025
#Lupuschat
#Lupus
Breaking Barriers: Advancing Disease Modification and Early Intervention in SLE & LN with Patient-Centered Strategies
@ladaorg.bsky.social
@lupuschat.bsky.social
#LUPUS2025
#Lupuschat
#Lupus
Breaking Barriers: Advancing Disease Modification and Early Intervention in SLE & LN with Patient-Centered Strategies
Professor Karen Costenbader
Director, Lupus Program, Brigham
@ladaorg.bsky.social
@lupuschat.bsky.social
#LUPUS2025
#Lupuschat
Breaking Barriers: Advancing Disease Modification and Early Intervention in SLE & LN with Patient-Centered Strategies
Professor Karen Costenbader
Director, Lupus Program, Brigham
@ladaorg.bsky.social
@lupuschat.bsky.social
#LUPUS2025
#Lupuschat
Stacy Payne Ardoin:
Targets in CV Disease in cSLE
Dr. Ardoin's clinical research focuses on optimal treatment and long-term outcomes of adults and children with lupus.
@ladaorg.bsky.social
@lupuschat.bsky.social
#LUPUS2025
#Lupuschat
#Lupus
Stacy Payne Ardoin:
Targets in CV Disease in cSLE
Dr. Ardoin's clinical research focuses on optimal treatment and long-term outcomes of adults and children with lupus.
@ladaorg.bsky.social
@lupuschat.bsky.social
#LUPUS2025
#Lupuschat
#Lupus
Pediatric Scientific Session: Outcomes and Targets in Children with SLE
Andrea M Knight:
Targets for the Management of NPSLE (Including Mental Health)
@ladaorg.bsky.social
@lupuschat.bsky.social
#LUPUS2025
#LupusChat
#Lupus
Pediatric Scientific Session: Outcomes and Targets in Children with SLE
Andrea M Knight:
Targets for the Management of NPSLE (Including Mental Health)
@ladaorg.bsky.social
@lupuschat.bsky.social
#LUPUS2025
#LupusChat
#Lupus
First Session today:
Pediatric Scientific Session: Outcomes and Targets in Children with SLE 💜🦋
Dr Eve Smith co-leads the International cSLE Treat-to-Target (T2T)
Let's work together to improve the care provided to children with lupus
#LUPUS2025
#LupusChat
#Lupus
First Session today:
Pediatric Scientific Session: Outcomes and Targets in Children with SLE 💜🦋
Dr Eve Smith co-leads the International cSLE Treat-to-Target (T2T)
Let's work together to improve the care provided to children with lupus
#LUPUS2025
#LupusChat
#Lupus
Happening Now :
The Future in Lupus 👈
What generative Al is and how it can be applied to improve SLE care
#LUPUS2025
#LupusChat
#Lupus
@ladaorg.bsky.social
@lupuschat.bsky.social
Happening Now :
The Future in Lupus 👈
What generative Al is and how it can be applied to improve SLE care
#LUPUS2025
#LupusChat
#Lupus
@ladaorg.bsky.social
@lupuschat.bsky.social
More than 65 countries 🌎 and over 1,000 registered 👥️
#Lupuschat #Lupus
@ladaorg.bsky.social
@lupuschat.bsky.social
More than 65 countries 🌎 and over 1,000 registered 👥️
#Lupuschat #Lupus
@ladaorg.bsky.social
@lupuschat.bsky.social
🦋 Let's spread the word! #Lupus is an autoimmune disease affecting approximately 3.4 MILLION people 👥️ in the world 🌎🌍🌏 and is associated with a wide range of symptoms, some of which are not always visible!
#LupusChat
@lupuschat.bsky.social
@ladaorg.bsky.social
🦋 Let's spread the word! #Lupus is an autoimmune disease affecting approximately 3.4 MILLION people 👥️ in the world 🌎🌍🌏 and is associated with a wide range of symptoms, some of which are not always visible!
#LupusChat
@lupuschat.bsky.social
@ladaorg.bsky.social
Conocimiento es Poder 💪 💜
#Lupus
#LupusChat
#LupusAwareness
#LupusAwarenessMonth
@lupuschat.bsky.social
@ladaorg.bsky.social
@lupusmadrid.bsky.social
@lupusdnadoc.bsky.social
Conocimiento es Poder 💪 💜
#Lupus
#LupusChat
#LupusAwareness
#LupusAwarenessMonth
@lupuschat.bsky.social
@ladaorg.bsky.social
@lupusmadrid.bsky.social
@lupusdnadoc.bsky.social
Aumentar educación 📚 y visibilidad son esenciales para crear una cultura👥 de comprensión y apoyo 💜
Raising Awareness and Visibility 📚 are essential to creating a culture 👥 of understanding and support
#LupusChat
##LupusAwareness
@lupuschat.bsky.social
@ladaorg.bsky.social
Aumentar educación 📚 y visibilidad son esenciales para crear una cultura👥 de comprensión y apoyo 💜
Raising Awareness and Visibility 📚 are essential to creating a culture 👥 of understanding and support
#LupusChat
##LupusAwareness
@lupuschat.bsky.social
@ladaorg.bsky.social
Difficult to part with
AND Impossible to Forget
Thank You Doctor Moorthy 💜🦋🥼
#LupusChat
#LupusAwareness
@lupuschat.bsky.social
@ladaorg.bsky.social
@lupusresearch.bsky.social
Difficult to part with
AND Impossible to Forget
Thank You Doctor Moorthy 💜🦋🥼
#LupusChat
#LupusAwareness
@lupuschat.bsky.social
@ladaorg.bsky.social
@lupusresearch.bsky.social
Thank You for Being an Amazing Rheumatologist!
We're so Thankful that we had you as part of Miah's healthcare team. Your kindness, expertise, and commitment to her well-being have made a tangible difference in her life.
#LupusChat
Thank You for Being an Amazing Rheumatologist!
We're so Thankful that we had you as part of Miah's healthcare team. Your kindness, expertise, and commitment to her well-being have made a tangible difference in her life.
#LupusChat
Thank U to ACR 4 including this groundbreaking session & @ladaorg.bsky.social @KathleenArntsen, Carrainc & @lupuschat.bsky.social 4 their support
#LupusChat
www.the-rheumatologist.org/issue/januar...
Thank U to ACR 4 including this groundbreaking session & @ladaorg.bsky.social @KathleenArntsen, Carrainc & @lupuschat.bsky.social 4 their support
#LupusChat
www.the-rheumatologist.org/issue/januar...
Como sabemos, puede llevar años obtener el diagnóstico adecuado de Lupus.
En nuestro caso, se necesitaba una "biopsia"🔬 de piel para obtener el diagnóstico de mi hija.
#LupusChat
Para mas información ⤵
Como sabemos, puede llevar años obtener el diagnóstico adecuado de Lupus.
En nuestro caso, se necesitaba una "biopsia"🔬 de piel para obtener el diagnóstico de mi hija.
#LupusChat
Para mas información ⤵
Aumentar educación 📚 y visibilidad son esenciales para crear una cultura👥 de comprensión y apoyo 💜
#LupusChat
Aumentar educación 📚 y visibilidad son esenciales para crear una cultura👥 de comprensión y apoyo 💜
#LupusChat